Fig. 21
From: In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Structure activity relationship based on molecular docking study for MCF-7 cell line
Fig. 21 | BMC Chemistry
From: In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Structure activity relationship based on molecular docking study for MCF-7 cell line